Nevada 2025 2025 Regular Session

Nevada Assembly Bill AB482 Introduced / Bill

                      
  
  	A.B. 482 
 
- 	*AB482* 
 
ASSEMBLY BILL NO. 482–COMMITTEE ON  
HEALTH AND HUMAN SERVICES 
 
MARCH 24, 2025 
____________ 
 
Referred to Committee on Health and Human Services 
 
SUMMARY—Revises provisions relating to Medicaid. 
(BDR 38-809) 
 
FISCAL NOTE: Effect on Local Government: No. 
 Effect on the State: Yes. 
 
~ 
 
EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted. 
 
 
AN ACT relating to Medicaid; requiring the State Plan for Medicaid 
to provide coverage for certain services relating to family 
planning and language translation; and providing other 
matters properly relating thereto. 
Legislative Counsel’s Digest: 
 Existing law requires the Director of the Department of Health and Human 1 
Services to develop, and the Department to administer, a State Plan for Medicaid, 2 
which includes coverage for certain contraceptive drugs and devices, including: (1) 3 
up to a 12-month supply of contraceptive drugs; (2) certain devices for 4 
contraception; and (3) voluntary sterilization for women. (NRS 422.063, 422.270, 5 
422.27172) This bill additionally requires the State Plan for Medicaid to cover: (1) 6 
voluntary sterilization for men; (2) clinical services relating to covered 7 
contraceptive drugs, devices and services; and (3) the cost of language translation 8 
services provided to facilitate the provision of covered contraceptive drugs, devices 9 
and services. This bill further requires the Division of Health Care Financing and 10 
Policy of the Department of Health and Human Services to develop a methodology 11 
establishing a rate of compensation for such translation services that is cost 12 
effective and comparable to the rate paid for translation services by other 13 
governmental entities that arrange for the provision of such services. This bill also 14 
requires the State Plan to cover certain contraceptive services when provided by 15 
any provider of health care for whom the services are within his or her scope of 16 
practice, training and experience, regardless of whether the services are provided in 17 
an inpatient or outpatient setting. 18 
 
   
 	– 2 – 
 
 
- 	*AB482* 
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN 
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: 
 
 Section 1.  NRS 422.27172 is hereby amended to read as 1 
follows: 2 
 422.27172 1. The Director shall include in the State Plan for 3 
Medicaid a requirement that the State pay the nonfederal share of 4 
expenditures incurred for: 5 
 (a) Up to a 12-month supply, per prescription, of any type of 6 
drug for contraception or its therapeutic equivalent which is: 7 
  (1) Lawfully prescribed or ordered; 8 
  (2) Approved by the Food and Drug Administration; and 9 
  (3) Dispensed in accordance with NRS 639.28075; 10 
 (b) Any type of device for contraception which is lawfully 11 
prescribed or ordered and which has been approved by the Food and 12 
Drug Administration; 13 
 (c) Self-administered hormonal contraceptives dispensed by a 14 
pharmacist pursuant to NRS 639.28078; 15 
 (d) Insertion or removal of a device for contraception, including, 16 
without limitation, the insertion of such a device at a hospital 17 
immediately after a person gives birth; 18 
 (e) A contraceptive injection, including, without limitation, such 19 
an injection immediately after a person gives birth. 20 
 (f) Education and counseling relating to the initiation of the use 21 
of contraceptives and any necessary follow-up after initiating such 22 
use; 23 
 (g) Management of side effects relating to contraception; [and] 24 
 (h) Voluntary sterilization [for women.] ; and 25 
 (i) Any clinical services relating to the drugs, devices and 26 
services described in paragraphs (a) to (h), inclusive. Such clinical 27 
services include, without limitation, services to monitor the use 28 
and effectiveness of contraception. 29 
 2.  Except as otherwise provided in subsections 4 and 5, to 30 
obtain any benefit provided in the Plan pursuant to subsection 1, a 31 
person enrolled in Medicaid must not be required to: 32 
 (a) Pay a higher deductible, any copayment or coinsurance; or 33 
 (b) Be subject to a longer waiting period or any other condition. 34 
 3. The Director shall ensure that the provisions of this section 35 
are carried out in a manner which complies with the requirements 36 
established by the Drug Use Review Board and set forth in the list 37 
of preferred prescription drugs established by the Department 38 
pursuant to NRS 422.4025. 39 
 4. The Plan may require a person enrolled in Medicaid to pay a 40 
higher deductible, copayment or coinsurance for a drug for 41   
 	– 3 – 
 
 
- 	*AB482* 
contraception if the person refuses to accept a therapeutic equivalent 1 
of the contraceptive drug. 2 
 5. For each method of contraception which is approved by the 3 
Food and Drug Administration, the Plan must include at least one 4 
contraceptive drug or device for which no deductible, copayment or 5 
coinsurance may be charged to the person enrolled in Medicaid, but 6 
the Plan may charge a deductible, copayment or coinsurance for any 7 
other contraceptive drug or device that provides the same method of 8 
contraception. If the Plan requires a person enrolled in Medicaid to 9 
pay a copayment or coinsurance for a drug for contraception, the 10 
Plan may only require the person to pay the copayment or 11 
coinsurance: 12 
 (a) Once for the entire amount of the drug dispensed for the plan 13 
year; or 14 
 (b) Once for each 1-month supply of the drug dispensed. 15 
 6.  The Plan must [provide] : 16 
 (a) Provide for the reimbursement of a pharmacist for providing 17 
services described in subsection 1 that are within the scope of 18 
practice of the pharmacist to the same extent as if the services were 19 
provided by another provider of health care. The Plan must not 20 
limit: 21 
 [(a)] (1) Coverage for such services provided by a pharmacist to 22 
a number of occasions less than the coverage for such services when 23 
provided by another provider of health care. 24 
 [(b)] (2) Reimbursement for such services provided by a 25 
pharmacist to an amount less than the amount reimbursed for similar 26 
services provided by a physician, physician assistant or advanced 27 
practice registered nurse. 28 
 (b) Provide for the reimbursement of a provider of health care 29 
for providing services described in subsection 1 if the services are 30 
within the scope of practice, training and experience of the 31 
provider of health care. 32 
 (c) Provide coverage for the services described in subsection 1 33 
regardless of whether those services are provided in an inpatient 34 
or outpatient setting. 35 
 7. The Plan must not require a recipient of Medicaid to obtain 36 
prior authorization for the benefits described in paragraphs (a) and 37 
(c) of subsection 1. 38 
 8. The Director shall include in the State Plan for Medicaid a 39 
requirement that the State pay the nonfederal share of 40 
expenditures incurred for the costs of any language translation 41 
services provided to facilitate the provision of any drugs, devices 42 
or services described in subsection 1. The Division shall develop a 43 
methodology establishing a rate of compensation for such 44 
translation services that is cost effective and comparable to the 45   
 	– 4 – 
 
 
- 	*AB482* 
rate paid for translation services by other governmental entities 1 
that arrange for the provision of such services. 2 
 9. As used in this section: 3 
 (a) “Drug Use Review Board” has the meaning ascribed to it in 4 
NRS 422.402. 5 
 (b) “Provider of health care” has the meaning ascribed to it in 6 
NRS 629.031. 7 
 (c) “Therapeutic equivalent” means a drug which: 8 
  (1) Contains an identical amount of the same active 9 
ingredients in the same dosage and method of administration as 10 
another drug; 11 
  (2) Is expected to have the same clinical effect when 12 
administered to a patient pursuant to a prescription or order as 13 
another drug; and 14 
  (3) Meets any other criteria required by the Food and Drug 15 
Administration for classification as a therapeutic equivalent. 16 
 Sec. 2.  1. This section becomes effective upon passage and 17 
approval. 18 
 2. Section 1 of this act becomes effective: 19 
 (a) Upon passage and approval for the purpose of adopting any 20 
regulations and performing any other preparatory administrative 21 
tasks that are necessary to carry out the provisions of this act; and 22 
 (b) On January 1, 2026, for all other purposes. 23 
 
H